Manish Sharma

4.7k total citations · 1 hit paper
218 papers, 2.8k citations indexed

About

Manish Sharma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Manish Sharma has authored 218 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Oncology, 50 papers in Pulmonary and Respiratory Medicine and 42 papers in Molecular Biology. Recurrent topics in Manish Sharma's work include Cancer Immunotherapy and Biomarkers (28 papers), CAR-T cell therapy research (23 papers) and Cancer Genomics and Diagnostics (22 papers). Manish Sharma is often cited by papers focused on Cancer Immunotherapy and Biomarkers (28 papers), CAR-T cell therapy research (23 papers) and Cancer Genomics and Diagnostics (22 papers). Manish Sharma collaborates with scholars based in United States, India and Canada. Manish Sharma's co-authors include Mark J. Ratain, Michael L. Maitland, Theodore Karrison, Richard L. Schilsky, Gini F. Fleming, Walter M. Stadler, Linda Janisch, Jason J. Luke, Sean P. Pitroda and Jeffrey M. Lemons and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Manish Sharma

190 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

2018 434 citations Jason J. Luke, Theodore Karrison et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manish Sharma United States	28	1.7k	593	576	545	495	218	2.8k
Barrett H. Childs United States	20	2.1k 1.3×	572 1.0×	585 1.0×	505 0.9×	731 1.5×	101	3.3k
Mustafa Beneklı Türkiye	24	1.2k 0.7×	623 1.1×	601 1.0×	291 0.5×	470 0.9×	182	2.6k
Steven J. Lemery United States	26	1.8k 1.1×	545 0.9×	852 1.5×	613 1.1×	627 1.3×	65	3.3k
Ki Y. Chung United States	20	1.6k 1.0×	617 1.0×	702 1.2×	256 0.5×	324 0.7×	62	2.4k
Philippe Bertheau France	26	1.2k 0.7×	730 1.2×	357 0.6×	718 1.3×	303 0.6×	78	2.9k
Ellis Levine United States	26	1.1k 0.7×	641 1.1×	946 1.6×	276 0.5×	289 0.6×	92	2.8k
Byron M. Espina United States	29	1.6k 1.0×	455 0.8×	1.0k 1.8×	433 0.8×	959 1.9×	73	3.5k
Kirsten B. Goldberg United States	39	2.7k 1.6×	979 1.7×	1.3k 2.2×	712 1.3×	349 0.7×	66	4.5k
Daniel E. Stepan United States	17	1.3k 0.8×	538 0.9×	627 1.1×	291 0.5×	260 0.5×	35	2.8k
Semra Paydaş Türkiye	28	1.0k 0.6×	627 1.1×	391 0.7×	319 0.6×	633 1.3×	208	2.7k

Countries citing papers authored by Manish Sharma

Since Specialization

Citations

This map shows the geographic impact of Manish Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manish Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manish Sharma more than expected).

Fields of papers citing papers by Manish Sharma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manish Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manish Sharma. The network helps show where Manish Sharma may publish in the future.

Co-authorship network of co-authors of Manish Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Manish Sharma. A scholar is included among the top collaborators of Manish Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manish Sharma. Manish Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagar, Gaurav, et al.. (2025). Validation of an AI Model for Automated Detection of Alveolar Bone Changes Post-orthodontics Using Cone-Beam Computed Tomography. Cureus. 17(10). e94809–e94809. 1 indexed citations

Falchook, Gerald S., Amita Patnaik, Debra L. Richardson, et al.. (2024). A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors. Clinical Therapeutics. 46(3). 228–238. 1 indexed citations

Wang, Judy S., David Sommerhalder, Manish Sharma, et al.. (2024). Phase 1/2 study of NGM707, an ILT2/ILT4 dual antagonist antibody, in advanced solid tumors: Interim results from dose-escalation.. Journal of Clinical Oncology. 42(16_suppl). 2582–2582. 2 indexed citations

Melero, Ignacio, Judy S. Wang, Martin Gutierrez, et al.. (2024). Cln-619 (anti-MICA/B antibody) alone and in combination with pembrolizumab (P) for advanced solid tumors: Updated results of a Ph1 study.. Journal of Clinical Oncology. 42(16_suppl). 2588–2588. 1 indexed citations

Papadopoulos, Kyriakos P., Manish Sharma, Reinhard Dummer, et al.. (2024). Results of a phase 1, dose-finding study of Debio 0123 as monotherapy in adult patients with advanced solid tumors: Safety, pharmacokinetic, and preliminary antitumor activity data.. Journal of Clinical Oncology. 42(16_suppl). 3120–3120. 5 indexed citations

Perets, Ruth, Manish Sharma, John H. Strickler, et al.. (2024). Phase 1b study evaluating the efficacy and safety of ABBV-400, a c-Met–targeting antibody-drug conjugate, in select advanced solid tumor indications.. Journal of Clinical Oncology. 42(16_suppl). TPS3162–TPS3162.

Sharma, Manish, John H. Strickler, David Sommerhalder, et al.. (2024). First-in-human study of ABBV-400, a novel c-Met–targeting antibody-drug conjugate, in advanced solid tumors: Results in colorectal cancer.. Journal of Clinical Oncology. 42(16_suppl). 3515–3515. 9 indexed citations

Khushalani, Nikhil I., Patrick A. Ott, Robert L. Ferris, et al.. (2024). Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer. 12(3). e007364–e007364. 18 indexed citations

Sharma, Manish, et al.. (2024). Comparison of Neurosensory Recovery of the Inferior Alveolar Nerve After Open and Closed Reduction for Mandibular Fractures: A Prospective Study. Cureus. 16(1). e53175–e53175.

10.

Park, Jong Chul, David Berz, Manish Sharma, et al.. (2023). 742 Phase 1/2 study of the bispecific 4–1BB and PD-L1 antibody INBRX-105 alone and in combination with pembrolizumab in select solid tumors. SHILAP Revista de lepidopterología. A836–A837. 2 indexed citations

11.

Sharma, Manish, et al.. (2023). Crop Recommendation System Using Machine Learning. International Journal for Research in Applied Science and Engineering Technology. 11(2). 640–644. 2 indexed citations

12.

Falchook, Gerald S., Drew Rasco, Kyriakos P. Papadopoulos, et al.. (2023). 128P A phase I dose escalation and expansion trial of LYT-200: A galectin-9 antibody +/- tislelizumab. Immuno-Oncology Technology. 20. 100600–100600. 1 indexed citations

13.

Meric‐Bernstam, Funda, Satish Shah, Manish Sharma, et al.. (2023). Sudocetaxel zendusortide (TH1902), a novel sortilin-receptor (SORT1)-targeting peptide-drug-conjugate (PDC) in patients (pts) with advanced solid tumors: Results from part 1 (dose-escalation) of a phase 1, open-label study.. Journal of Clinical Oncology. 41(16_suppl). 3089–3089. 2 indexed citations

14.

Münster, Pamela N., Andrew E. Greenstein, Gini F. Fleming, et al.. (2022). Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors. Clinical Cancer Research. 28(15). 3214–3224. 20 indexed citations

15.

Maitland, Michael L., Jasgit C. Sachdev, Manish Sharma, et al.. (2021). First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors. Clinical Cancer Research. 27(16). 4511–4520. 63 indexed citations

16.

Gupta, Manoj, et al.. (2020). A Walk with Lu-177 PSMA: How Close we Have Reached from Bench to Bedside?. Cancer Investigation. 38(8-9). 486–492. 4 indexed citations

17.

Foster, Corey C., Larissa V. Furtado, John Hart, et al.. (2018). Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy. PLoS ONE. 13(3). e0194234–e0194234. 6 indexed citations

18.

Sharma, Manish, et al.. (2017). Morphological studies on Parasarcophaga albiceps, Parasarcophaga macroauriculata and Parasarcophaga ruficornis (Diptera: Sarcophagidae) of Indian origin. International Journal of Fauna and Biological Studies. 4(4). 155–161. 2 indexed citations

19.

Toffoli, Giuseppe, Manish Sharma, Elena Marangon, et al.. (2016). Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 23(4). 918–924. 31 indexed citations

20.

Sharma, Manish, Theodore Karrison, Yuyan Jin, et al.. (2012). Resampling Phase III Data to Assess Phase II Trial Designs and Endpoints. Clinical Cancer Research. 18(8). 2309–2315. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact